Group One Trading
RGC icon

Group One Trading’s Regencell Bioscience RGC Stock Holding History

Group One Trading’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.09K Hold
200
– – ﹤0.01% 6705
2025
Q4 		$4.2K Sell
200
-900
-82% -$14.6K ﹤0.01% 7260
2025
Q3 		$17K Buy
+1,100
New +$15.8K ﹤0.01% 6822

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Group One Trading's RGC Position: Q1 2026 in Review

Group One Trading opened a new position in Regencell Bioscience (RGC) in Q1 2026: 354 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #6423 among its holdings. This is a return to the name: Group One Trading previously reported a position in RGC as recently as Q3 2025.

Group One Trading first reported a position in RGC in Q3 2025 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold RGC as of Q1 2026.

  • Group One Trading held 354 shares of Regencell Bioscience worth $9K as of Q1 2026.
  • Regencell Bioscience was a new Group One Trading position in Q1 2026.
  • Regencell Bioscience made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6423 holding.
  • Group One Trading first reported a position in Regencell Bioscience in Q3 2025 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.